SK

Sunil Kumar

Active Director Director DIN 08185213
DIN 08185213 First appointment Oct 2017 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2017
Shareholding value •••• Premium profile

About Sunil Kumar

Data last updated:

Sunil Kumar is a Director at Dewelt Pharma Private Limited (since 2017). The company operates in Chemicals. Dewelt Pharma Private Limited reported revenue of ₹3.9 Lakh (FY 2017).

DIN 08185213
Primary Designation Director
Industry Chemicals
First Appointment 04 Oct 2017
Oldest Company Age 13 yrs
Largest company Dewelt Pharma Private Limited · ₹3.9 Lakh (FY 2017)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dewelt Pharma Private Limited U74220UR2013PTC000804
Director04 Oct 20172013₹3.9 Lakh (FY 2017)Active

Board colleagues of Sunil Kumar

NameDINCompanyDesignation
Vinod06594927Dewelt Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Dewelt Pharma Private Limited
Premium access

Shareholding and investment profile for Sunil Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunil Kumar

Sunil Kumar currently holds 1 directorship: Dewelt Pharma Private Limited (Director, since 04 Oct 2017, revenue ₹3.9 Lakh (FY 2017)).

Sunil Kumar was first appointed on 04 Oct 2017 as Director at Dewelt Pharma Private Limited.

The current boards of Sunil Kumar's companies include Vinod (Dewelt Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available